Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2361608 | 0.97 | — | — | |
| Ammonia Solution, Strong SCHEMBL28832389 | 0.94 | CA12 (0.43) | CA12CA1CA2CA9ADRB2 | |
| SCHEMBL3973874 | 0.88 | CA12 (0.56) | CA12CA1CA2CA9ADRB2 | |
| SCHEMBL12918862 | 0.88 | CA12 (0.56) | CA12CA1CA2CA9ADRB2 | |
| SCHEMBL19801514 | 0.87 | CA12 (0.40) | CA12CA1CA2CA9ADRB2 | |
| SCHEMBL16298585 | 0.86 | CA12 (0.38) | CA12CA1CA2CA9ADRB2 | |
| Ammonia Solution, Strong SCHEMBL17238502 | 0.85 | CA12 (0.54) | CA12CA1CA2CA9ADRB2 | |
| SCHEMBL15091 | 0.85 | CA12 (0.52) | CA12CA1CA2CA9ADRB2 | |
| SCHEMBL13668206 | 0.84 | DNM1 (0.46) | CA12CA1CA2CA9KDM4E | |
| SCHEMBL12865461 | 0.83 | LMNA (0.40) | CA12CA1CA2CA9KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024054953-A1 | HETEROBIFUNCTIONAL COMPOUNDS AND METHODS OF TREATING DISEASE | HALDA THERAPEUTICS OPCO, INC. (US) | 2024-03-14 | — | — | WO | disclosed |
| WO-2019013790-A1 | ANTIMICROBIAL COMPOUNDS AND USES THEREOF | CURZA GLOBAL, LLC (US) | 2019-01-17 | — | — | WO | disclosed |
| EP-3148674-B1 | ABSORBENT SOLUTION CONTAINING A MIXTURE OF 1,2-BIS-(2-DIMETHYLAMINOETHOXY)-ETHANE AND 2-[2-(2- DIMETHYLAMINOETHOXY)-ETHOXY]-ETHANOL, AND METHOD FOR ELIMINATING ACID COMPOUNDS FROM A GAS EFFLUENT | IFP ENERGIES NOW (FR) | 2018-07-11 | — | — | EP | disclosed |
| US-9962645-B2 | Absorbent solution containing a mixture of 1,2-bis-(2-dimethylaminoethoxy)-ethane and of 2-[2-(2-dimethylaminoethoxy)-ethoxy]-ethanol, and method of removing acid compounds from a gaseous effluent | IFP Energies Nouvelles (FR) | 2018-05-08 | — | — | US | disclosed |
| US-20170197176-A1 | ABSORBENT SOLUTION CONTAINING A MIXTURE OF 1,2-BIS-(2-DIMETHYLAMINOETHOXY)-ETHANE AND OF 2-[2-(2-DIMETHYLAMINOETHOXY)-ETHOXY]-ETHANOL, AND METHOD OF REMOVING ACID COMPOUNDS FROM A GASEOUS EFFLUENT | IFP Energies Nouvelles (FR) | 2017-07-13 | — | — | US | disclosed |
| EP-2653484-B1 | SURFACE MODIFICATION METHOD, SURFACE-MODIFIED ELASTIC BODY, SYRINGE GASKET, SYRINGE, AND TIRE | SUMITOMO RUBBER IND (JP) | 2017-02-15 | — | — | EP | disclosed |
| US-20150005319-A1 | MACROCYCLIC COMPOUNDS FOR MODULATING IL-17 | ENSEMBLE THERAPEUTICS CORPORATION | 2015-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150005319-A1 | MACROCYCLIC COMPOUNDS FOR MODULATING IL-17 | IL17A, IL15, IL2 | CA12 4051/4885CA1 4748/4885CA2 4758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.